-
Latest News
Archives
Tag Archives: Jonathan Kerr
Responses in BMJ to Prof Sharpe on PACE trial
Pressure grows on Lancet to review “flawed” PACE trial On 22 August Ingrid Torjesen wrote a news item in the British Medical Journal about an article in the Times which highlighted the call to review the results of the PACE trial into … Continue reading
Posted in News
Tagged BMJ, Dr Ellen CG Grant, Ingrid Torjesen, Jonathan Kerr, NAsim MArie Jafry, PACE trial, Prof Jonathan Edwards, Prof Michael Sharpe
Comments Off on Responses in BMJ to Prof Sharpe on PACE trial
ME/CFS in Colombian workers
Research abstract: Background: Chronic Fatigue Syndrome/Myalgic encephalomyelitis (CFS/ME) is a debilitating and complex disease characterised by intense fatigue and a variety of other symptoms, which are present for at least 6 months. Studies of CFS/ME in the working population are … Continue reading
Posted in News
Tagged Colombia, Jonathan Kerr, occupational health, Ximena Rincon
Comments Off on ME/CFS in Colombian workers
MicroRNAs as potential biomarkers in ME/CFS
ME Research UK comments on recent research: MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME), by RD Petty, NE McCarthy, R Le Dieu, J R … Continue reading
Posted in News
Tagged biomarkers, gene expression, Jonathan Kerr, ME Research UK, microRNAs, miRNA
Comments Off on MicroRNAs as potential biomarkers in ME/CFS
Potential diagnostic biomarkers in Natural Killer cells of patients with CFS/ ME
Research abstract: BACKGROUND: Chronic Fatigue Syndrome (CFS/ME) is a complex multisystem disease of unknown aetiology which causes debilitating symptoms in up to 1% of the global population. Although a large cohort of genes have been shown to exhibit altered expression … Continue reading
Posted in News
Tagged gene expression, Jonathan Kerr, microanalysis array, Natural Killer cells
Comments Off on Potential diagnostic biomarkers in Natural Killer cells of patients with CFS/ ME